Stimulatory Effect of Tofacitinib on Bone Marrow Adipocytes Differentiation
BackgroundSystemic inflammation is the main factor underlying secondary osteoporosis in patients with rheumatoid arthritis (RA). Janus kinase inhibitors (JAKi), such as tofacitinib (Tofa), can control systemic inflammation and may have beneficial effects on bone in various models. This might be due...
Main Authors: | Jean-Guillaume Letarouilly, Julien Paccou, Sammy Badr, Christophe Chauveau, Odile Broux, Aline Clabaut |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.881699/full |
Similar Items
-
Bone Marrow Adipocytes: A Critical Player in the Bone Marrow Microenvironment
by: Lipeng Wang, et al.
Published: (2021-11-01) -
Morphological and Immunophenotypical Changes of Human Bone Marrow Adipocytes in Marrow Metastasis and Myelofibrosis
by: Michele Dello Spedale Venti, et al.
Published: (2022-06-01) -
Therapeutic Irradiation: Consequences for Bone and Bone Marrow Adipose Tissue
by: Samantha Costa, et al.
Published: (2019-08-01) -
Brief Report From the 4th International Meeting on Bone Marrow Adiposity (BMA2018)
by: Guillaume Penel, et al.
Published: (2019-10-01) -
The extracellular matrix of human bone marrow adipocytes and glucose concentration differentially alter mineralization quality without impairing osteoblastogenesis
by: Laura Entz, et al.
Published: (2022-12-01)